Fingerprint
Dive into the research topics of 'Pembrolizumab as second-line therapy for advanced urothelial carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pembrolizumab as second-line therapy for advanced urothelial carcinoma
Joaquim Bellmunt, Ronald de Wit, David J. Vaughn, Yves Fradet, Jae-Lyun Lee, Lawrence Fong, Nicholas J. Vogelzang, Miguel A. Climent, Daniel P. Petrylak, Toni K. Choueiri, Andrea Necchi, Winald Gerritsen, Howard Gurney, David I. Quinn, Stéphane Culine, Cora N. Sternberg, Yabing Mai, Christian H. Poehlein, Rodolfo F. Perini, Dean F. Bajorin
Research output: Contribution to journal › Article › peer-review
1602
Citations
(Scopus)